BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5577431)

  • 1. [Therapeutic results with 1035 MD (apropos of 92 cases)].
    Delteil P; Douche F; Fromentin M
    Ann Med Psychol (Paris); 1971 Feb; 1(2):261-8. PubMed ID: 5577431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Restructuring action of Sureptil in anxio-depressive components of involutive states].
    Carrère J
    Ann Med Psychol (Paris); 1970 Oct; 2(3):409-19. PubMed ID: 5481455
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of 1035 M. D. in neuropsychic syndromes of vascular origin and certain involutional psychoses].
    Ey H; Bohard F
    Ann Med Psychol (Paris); 1967 Dec; 2(5):767-71. PubMed ID: 5585706
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic use of a nicofuranosio-centrophenoxine association in involutive psychoses].
    Viviano M; Ceccarelli G
    Minerva Med; 1966 Nov; 57(94):3965-9. PubMed ID: 4380869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electro-clinical study on value of M.D. 1035 in psychiatry].
    Ey H; Barros-Fereira M; Bohard F; Natin JC
    Ann Med Psychol (Paris); 1970 Mar; 1(3):455-65. PubMed ID: 5424185
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of clinical and encephalographic action of 1035 MD in child neuropsychiatry. Apropos of 33 cases followed during a year].
    Savelli A; Rigal J
    Rev Neuropsychiatr Infant; 1974 Mar; 22(3):199-205. PubMed ID: 4841032
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene].
    Bornstein S; Sère de Rivières H
    Therapeutique; 1972 Jan; 48(1):27-34. PubMed ID: 5046366
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-statistical evaluation on the use in psycho-geriatrices of fluoxymesterone].
    De Maio D; Ferrazzi D
    Minerva Med; 1969 Jan; 60(8):315-9. PubMed ID: 5766860
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trial of 1035 MD in a population of mentally retarded subjects in medico-pedagogic institutes].
    Besançon G; Blineau-Vecchierini MF
    Rev Neuropsychiatr Infant; 1973 Sep; 21(9):565-8. PubMed ID: 4586339
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dynamics of the clinico-pathophysiologic characteristics of psychoses in old age under the influence of azafen].
    Taranskaia AD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):440-3. PubMed ID: 1266520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Participation of a new cerebral vasodilator, 1,035 M.D. in the involutional psychoses of chronic alcoholism].
    Ducamin JP; Cron
    Encephale; 1969; 58(3):283-7. PubMed ID: 5378186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dehydrobenzperidol (dbp) in psychiatry: clinical experiences].
    Escalar G; Saccani P
    Riv Sper Freniatr Med Leg Alien Ment; 1968 Aug; 92(4):1168-92. PubMed ID: 5738065
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of phychotonic drugs in neuropsychiatry].
    Bánki C
    Orv Hetil; 1976 Feb; 117(5):283-6. PubMed ID: 1250597
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical therapeutic experiences with fluphenazine].
    Pfeiffer WM
    Arzneimittelforschung; 1967 Oct; 17(10):1327-9. PubMed ID: 5632888
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with the new phenothiazine derivative chlorimpiphenine].
    Reimer F; Christiani K
    Med Klin; 1967 Sep; 62(39):1515-6. PubMed ID: 5596491
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with Cinnarizin (Stugeron) in the treatment of arteriosclerotic and post-traumatic psychosyndromes].
    Voina S
    Schweiz Rundsch Med Prax; 1970 Aug; 59(32):1165-70. PubMed ID: 5513338
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of 100 observations on the activity of 1035 M.D. in various neuro-psychiatric disorders due to cerebrovascular insufficiency].
    Digo R; Bellot JC
    Encephale; 1969; 58(3):267-82. PubMed ID: 5378185
    [No Abstract]   [Full Text] [Related]  

  • 18. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and experimental experience with the nicotinic acid ester 7-oxyethyltheophylline].
    Fischbach R; Haas R
    Arzneimittelforschung; 1967 Mar; 17(3):313-7. PubMed ID: 5631222
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined therapy with vasodilator and lipid-clearing drugs in cerebrovascular insufficiency in advanced old age].
    Giovanardi F; Bisceglia G
    Clin Ter; 1971 Aug; 58(3):243-53. PubMed ID: 5135003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.